126 related articles for article (PubMed ID: 34520099)
21. Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
Bennett CL; Stinson TJ; Lane D; Amylon M; Land VJ; Laver JH
Med Pediatr Oncol; 2000 Feb; 34(2):92-6. PubMed ID: 10657867
[TBL] [Abstract][Full Text] [Related]
22. Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015-2019 in Guangdong, China.
Zhan C; Wu Z; Yang L; Yu L; Deng J; Luk K; Duan C; Zhang L
BMC Health Serv Res; 2022 Feb; 22(1):229. PubMed ID: 35183172
[TBL] [Abstract][Full Text] [Related]
23. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
[TBL] [Abstract][Full Text] [Related]
24. An overview of childhood cancer care and outcomes in Egypt: a narrative review.
Soliman R; Bolous N; Heneghan C; Oke J; Boylan AM; Eweida W; Abouelnaga S; Elhaddad A
Ecancermedicalscience; 2024; 18():1676. PubMed ID: 38439811
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children's Cancer Hospital Egypt, 2007-17.
Semary SF; Hammad M; Soliman S; Yassen D; Gamal M; Albeltagy D; Hamdy N; Mahmoud S
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e529-e541. PubMed ID: 32473792
[TBL] [Abstract][Full Text] [Related]
26. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang YS; Arnold S; Seif AE; Miller TP; Bagatell R; Fisher BT; Adamson PC; Gamis A; Keren R; Aplenc R
Pediatr Blood Cancer; 2015 Oct; 62(10):1775-81. PubMed ID: 25946708
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
28. Analysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China.
Jiang C; Cai S; Duan C; Xu N; Zhou Y; Peng X; Ma X
J Med Econ; 2020 Sep; 23(9):961-966. PubMed ID: 32568600
[TBL] [Abstract][Full Text] [Related]
29. Outcome of Childhood Acute Megakaryoblastic Leukemia: Children's Cancer Hospital Egypt 57357 Experience.
Maarouf N; Mahmoud S; Khedr R; Lehmann L; Shaaban K; Ibrahim S; Fahmy S; Hassanain O; Nader N; Elhaddad A
Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):e142-e152. PubMed ID: 30686774
[TBL] [Abstract][Full Text] [Related]
30. Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232.
DiNofia AM; Seif AE; Devidas M; Li Y; Hall M; Huang YV; Cahen V; Hunger SP; Winick NJ; Carroll WL; Fisher BT; Larsen EC; Aplenc R
Cancer Med; 2018 Jan; 7(1):3-12. PubMed ID: 29274118
[TBL] [Abstract][Full Text] [Related]
31. Barriers and Facilitators to Implementing Cost-Effective Evidence-Based Childhood Cancer Treatment in a Resource-Limited Setting in Egypt: A Qualitative Interview Study.
Soliman R; Heneghan C; Boylan AM; Oke J; Eweida W; Elhaddad A
JCO Glob Oncol; 2023 Jun; 9():e2200424. PubMed ID: 37290021
[TBL] [Abstract][Full Text] [Related]
32. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.
Fedele PL; Avery S; Patil S; Spencer A; Haas M; Wei A
Intern Med J; 2014 Aug; 44(8):757-63. PubMed ID: 24863325
[TBL] [Abstract][Full Text] [Related]
33. Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.
Kabra M; Margotto L; Manuguid F
Future Oncol; 2021 Jul; 17(21):2769-2784. PubMed ID: 33881356
[TBL] [Abstract][Full Text] [Related]
34. Auditing Practice Style Variation in Pediatric Inpatient Asthma Care.
Silber JH; Rosenbaum PR; Wang W; Ludwig JM; Calhoun S; Guevara JP; Zorc JJ; Zeigler A; Even-Shoshan O
JAMA Pediatr; 2016 Sep; 170(9):878-86. PubMed ID: 27398908
[TBL] [Abstract][Full Text] [Related]
35. A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia.
Pickard AS; Topfer LA; Feeny DH
J Natl Cancer Inst Monogr; 2004; (33):102-25. PubMed ID: 15504922
[TBL] [Abstract][Full Text] [Related]
36. Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility analysis.
Maser B; Pelland-Marcotte MC; Alexander S; Sung L; Gupta S
Pediatr Blood Cancer; 2020 Oct; 67(10):e28643. PubMed ID: 32785971
[TBL] [Abstract][Full Text] [Related]
37. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.
Elzomor H; Taha H; Nour R; Aleieldin A; Zaghloul MS; Qaddoumi I; Alfaar AS
Ophthalmic Genet; 2017; 38(4):345-351. PubMed ID: 28085527
[TBL] [Abstract][Full Text] [Related]
38. Community household income and resource utilization for common inpatient pediatric conditions.
Fieldston ES; Zaniletti I; Hall M; Colvin JD; Gottlieb L; Macy ML; Alpern ER; Morse RB; Hain PD; Sills MR; Frank G; Shah SS
Pediatrics; 2013 Dec; 132(6):e1592-601. PubMed ID: 24276839
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States.
Bell JA; Galaznik A; Farrelly E; Blazer M; Murty S; Ogbonnaya A; Eaddy M; Fram RJ; Faller DV; Kota V
Leuk Res; 2018 Aug; 71():27-33. PubMed ID: 29944984
[TBL] [Abstract][Full Text] [Related]
40. Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada.
de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
Value Health; 2017 Mar; 20(3):345-356. PubMed ID: 28292479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
